Univariate analysis of the effect of this mutation on DFS of patients showed that C228T TERT promoter mutation was significantly associated with an increased risk of tumor relapse (HR = 3.372; 95% CI: 1.17–9.73; p = 0.025; Table 3). The gene discussed is TERT; the disease is neoplasm.